The pharmacology of bisphosphonates and new insights into their mechanisms of action

被引:202
作者
Russell, RGG
Rogers, MJ
Frith, JC
Luckman, SP
Coxon, FP
Benford, HL
Croucher, PI
Shipman, C
Fleisch, HA
机构
[1] Univ Sheffield, Sch Med, Dept Human Metab & Clin Biochem, Sheffield S10 2RX, S Yorkshire, England
[2] Univ Aberdeen, Dept Med & Therapeut, Bone Res Grp, Aberdeen, Scotland
关键词
D O I
10.1002/jbmr.5650140212
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Bisphosphonates are chemically stable analogs of inorganic pyrophosphate, which are resistant to breakdown by enzymatic hydrolysis, The biological effects of bisphosphonates on calcium metabolism were originally ascribed to their physico-chemical effects on hydroxyapatite crystals. Although such effects may contribute to their overall action, their effects on cells are probably of greater importance, particularly for the more potent compounds. Remarkable progress has been made in increasing the potency of bisphosphonates as inhibitors of bone resorption, and the most potent compounds in current use are characterized by the presence of a nitrogen atom at critical positions in the side chain which, together with the bisphosphonate moiety itself, seems to be essential for maximal activity, As a class the bisphosphonates offer a very effective means of treating Paget's disease.
引用
收藏
页码:53 / 65
页数:13
相关论文
共 141 条
[21]   The management of Paget's disease of bone [J].
Delmas, PD ;
Meunier, PJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (08) :558-566
[22]   Reduction in new metastases in breast cancer with adjuvant clodronate treatment [J].
Diel, IJ ;
Solomayer, EF ;
Costa, SD ;
Gollan, C ;
Goerner, R ;
Wallwiener, D ;
Kaufmann, M ;
Bastert, G .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (06) :357-363
[23]  
DOUGLAS DL, 1980, LANCET, V1, P1043
[24]  
Ebetino FH, 1996, PHOSPHORUS SULFUR, V109, P217
[25]  
Ebetino FH, 1998, REV CONTEMP PHARMACO, V9, P233
[26]  
EBRAHIMPOUR A, 1995, BISPHOSPHONATE BONES
[27]  
Endo N, 1996, J BONE MINER RES, V11, P535
[28]   EFFECT OF SEVERAL DIPHOSPHONATES ON ACID PHOSPHOHYDROLASES AND OTHER LYSOSOMAL ENZYMES [J].
FELIX, R ;
RUSSELL, RGG ;
FLEISCH, H .
BIOCHIMICA ET BIOPHYSICA ACTA, 1976, 429 (02) :429-438
[29]  
FERRETTI JL, 1995, BISPHOSPHONATE BONES
[30]   Alendronate mechanism of action:: geranylgeraniol, an intermediate in the mevalonate pathway, prevents inhibition of osteoclast formation, bone resorption, and kinase activation in vitro [J].
Fisher, JE ;
Rogers, MJ ;
Halasy, JM ;
Luckman, SP ;
Hughes, DE ;
Masarachia, PJ ;
Wesolowski, G ;
Russell, RGG ;
Rodan, GA ;
Reszka, AA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (01) :133-138